200 related articles for article (PubMed ID: 34685368)
21. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
Sader HS; Farrell DJ; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
[TBL] [Abstract][Full Text] [Related]
22. [An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011].
Chen HB; Zhao CJ; Wang H; Cao B; Xu XL; Chu YZ; Hu ZD; Zhuo C; Hu BJ; Liu WE; Liao K; Zhang R; Zeng J; Wang Y; Luo YP; Wang ZW; Liu YM; Chen X; Tian B; Su DH; Zhou CM; Zou MX; Guo PH; Zhou HW; Jin Y
Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):203-12. PubMed ID: 23856111
[TBL] [Abstract][Full Text] [Related]
23. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.
Iosifidis E; Antachopoulos C; Tsivitanidou M; Katragkou A; Farmaki E; Tsiakou M; Kyriazi T; Sofianou D; Roilides E
Infect Control Hosp Epidemiol; 2008 Jul; 29(7):615-22. PubMed ID: 18624668
[TBL] [Abstract][Full Text] [Related]
24. Five-Year Antimicrobial Susceptibility Trends Among Bacterial Isolates from a Tertiary Health-Care Facility in Kigali, Rwanda.
Carroll M; Rangaiahagari A; Musabeyezu E; Singer D; Ogbuagu O
Am J Trop Med Hyg; 2016 Dec; 95(6):1277-1283. PubMed ID: 27799637
[TBL] [Abstract][Full Text] [Related]
25. Major Bloodstream Infection-Causing Bacterial Pathogens and Their Antimicrobial Resistance in South Korea, 2017-2019: Phase I Report From Kor-GLASS.
Kim D; Yoon EJ; Hong JS; Choi MH; Kim HS; Kim YR; Kim YA; Uh Y; Shin KS; Shin JH; Park JS; Park KU; Won EJ; Kim SH; Shin JH; Kim JW; Lee S; Jeong SH
Front Microbiol; 2021; 12():799084. PubMed ID: 35069503
[TBL] [Abstract][Full Text] [Related]
26. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Piérard D; Stone GG
BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
Morfin-Otero R; Noriega ER; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
29. Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
Namdari H; Tan TY; Dowzicky MJ
Int J Infect Dis; 2012 Jan; 16(1):e60-6. PubMed ID: 22104303
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004-2014.
Marco F; Dowzicky MJ
J Glob Antimicrob Resist; 2016 Sep; 6():50-56. PubMed ID: 27530839
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018].
Li SG; Liao K; Su DH; Zhuo C; Chu YZ; Hu ZD; Xu XL; Zhang R; Liu WE; Lu BH; Zeng J; Jin Y; Wang H
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3775-3783. PubMed ID: 33379842
[No Abstract] [Full Text] [Related]
32. [A multicenter, retrospective study of pathogenic bacteria distribution and drug resistance in febrile neutropenic patients with hematological diseases in Shanghai].
Zhu J; Hu J; Mao YF; Chen FY; Zhu JY; Shi JM; Yu DD; Hao SG; Tao R; Liu P; Gu SY; Hou J; He HY; Liang AB; Ding Y; Liu LG; Xie YH; Zhu Q; Yu YH; Yao YH; Chen W; Xu HL; Han XH; Wang C
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):945-950. PubMed ID: 29224317
[No Abstract] [Full Text] [Related]
33. [Surveillance of bacterial resistance in children aged 0-14 years from 2018 to 2022].
China Antimicrobial Resistance Surveillance System
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):1001-1010. PubMed ID: 37855078
[No Abstract] [Full Text] [Related]
34. Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non-Typhoidal Salmonella Species in Korea: A KONSAR Study Conducted in 2011.
Yong D; Shin HB; Kim YK; Cho J; Lee WG; Ha GY; Choi TY; Jeong SH; Lee K; Chong Y;
Infect Chemother; 2014 Jun; 46(2):84-93. PubMed ID: 25024870
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.
Bertrand X; Dowzicky MJ
Clin Ther; 2012 Jan; 34(1):124-37. PubMed ID: 22154196
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial Susceptibility Trends Among Gram-Negative Bacilli Causing Bloodstream Infections: Results from the China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2011-2020.
Yan M; Zheng B; Li Y; Lv Y
Infect Drug Resist; 2022; 15():2325-2337. PubMed ID: 35517902
[TBL] [Abstract][Full Text] [Related]
38. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
[TBL] [Abstract][Full Text] [Related]
40. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
